These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29020897)

  • 41. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
    Tan-Koi WC; Sung C; Chong YY; Lateef A; Pang SM; Vasudevan A; Aw D; Lui NL; Lee SX; Ren EC; Koay ES; Tay YK; Lim YL; Lee HY; Dong D; Loke C; Tan L; Limenta M; Lee EJ; Toh D; Chan CL
    Pharmacogenomics; 2017 Jun; 18(9):881-890. PubMed ID: 28594314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous drug reaction case reports: from the world literature.
    Am J Clin Dermatol; 2002; 3(6):439-44. PubMed ID: 12113652
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cutaneous drug reactions. A special challenge for dermatologists].
    Ständer S; Mockenhaupt M
    Hautarzt; 2014 May; 65(5):396. PubMed ID: 24820796
    [No Abstract]   [Full Text] [Related]  

  • 45. Recognizing and preventing adverse drug reactions: with particular reference to drug eruptions.
    Chan HL
    Singapore Med J; 2000 Nov; 41(11):519-20. PubMed ID: 11284607
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-induced IgA bullous dermatosis: a rare presentation of SLE.
    Ozdemir G; Koyun M; Baysal YE; Gür Güven A; Dicle O; Ciftçioğlu A; Akman S
    Clin Exp Rheumatol; 2010; 28(4):589. PubMed ID: 20663403
    [No Abstract]   [Full Text] [Related]  

  • 47. Cutaneous drug reactions.
    Rubianes EI; Martín RF; Picó M; González JR
    Bol Asoc Med P R; 1990 Oct; 82(10):434-42. PubMed ID: 2150483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin toxicity of anti-cancer therapy.
    Ulrich J; Hartmann JT; Dörr W; Ugurel S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions.
    Pirmohamed M; Aithal GP; Behr E; Daly A; Roden D
    Clin Pharmacol Ther; 2011 Jun; 89(6):784-5. PubMed ID: 21593754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions.
    Dodiuk-Gad RP; Chung WH; Yang CH; Lu CW; Hui RC; Shear NH
    Drug Saf; 2014 Jun; 37(6):459-64. PubMed ID: 24788802
    [No Abstract]   [Full Text] [Related]  

  • 51. [Drug-eruptions].
    Thielen AM; Toutous-Trellu L; Desmeules J
    Rev Med Suisse; 2008 Jul; 4(165):1671-5. PubMed ID: 18767294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DRESS syndrome presenting like septic shock.
    Parkins G; White B
    QJM; 2013 Jul; 106(7):671-3. PubMed ID: 23474419
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug eruptions; their causation and treatment.
    PETERKIN GA
    Postgrad Med; 1959 Jan; 25(1):2-10. PubMed ID: 13614070
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cutaneous adverse effects of TNFalpha antagonists].
    Failla V; Sabatiello M; Lebas E; de Schaetzen V; Dezfoulian B; Nikkels AF
    Rev Med Liege; 2012; 67 Spec No():3-7. PubMed ID: 22690479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug Safety.
    Feldman S
    J Dermatolog Treat; 2009; 20(2):71. PubMed ID: 19319706
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of dermatologic toxicities.
    Lacouture ME
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):686-9. PubMed ID: 25995431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug reactions.
    ROSTENBERG A
    Postgrad Med; 1958 Sep; 24(3):263-70. PubMed ID: 13591088
    [No Abstract]   [Full Text] [Related]  

  • 58. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions.
    Barbaud A; Gonçalo M; Bruynzeel D; Bircher A;
    Contact Dermatitis; 2001 Dec; 45(6):321-8. PubMed ID: 11846746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug reactions of importance in daily practice.
    YOUMAN JD
    J La State Med Soc; 1953 Oct; 105(10):380-5. PubMed ID: 13096959
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacogenomics of severe cutaneous adverse reactions.
    Kaniwa N; Saito Y
    Pharmacogenomics; 2013 Apr; 14(6):595-8. PubMed ID: 23570461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.